Morality and marketing human organs
Recent break-throughs in surgery and the discovery of an effective immunosupressive drug called cyclosporin, have brought a Renaissance in organ transplants. These medical advances have also heightened concern over the already critical shortage of body organs. Several alternatives have been suggeste...
| Autore principale: | |
|---|---|
| Tipo di documento: | Elettronico Articolo |
| Lingua: | Inglese |
| Verificare la disponibilità: | HBZ Gateway |
| Journals Online & Print: | Caricamento...
|
| Fernleihe: | Fernleihe für die Fachinformationsdienste |
| Pubblicazione: |
Springer Science + Business Media B. V
1987
|
| In: |
Journal of business ethics
Anno: 1987, Volume: 6, Fascicolo: 1, Pagine: 37-44 |
| Altre parole chiave: | B
Organ Transplant
B Cyclosporin B Medical Advance B Economic Growth B Marketing |
| Accesso online: |
Volltext (JSTOR) Volltext (lizenzpflichtig) |
| Riepilogo: | Recent break-throughs in surgery and the discovery of an effective immunosupressive drug called cyclosporin, have brought a Renaissance in organ transplants. These medical advances have also heightened concern over the already critical shortage of body organs. Several alternatives have been suggested which may help alleviate the organ shortage. One such alternative is to allow commerce in human organs. This article discusses the morality of commercialization of human organs within the framework of several ethical theories. |
|---|---|
| ISSN: | 1573-0697 |
| Comprende: | Enthalten in: Journal of business ethics
|
| Persistent identifiers: | DOI: 10.1007/BF00382946 |